
Chembio Diagnostics CEMI
Annual report 2022
added 03-29-2023
Chembio Diagnostics P/CF Ratio 2011-2026 | CEMI
Annual P/CF Ratio Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.991 | -0.897 | -5.75 | -5.28 | -7.63 | -16.8 | -8.48 | 61.6 | -6.76 | 23.6 | -377 | 19.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.6 | -377 | -27.1 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 17.01 | -0.12 % | $ 179 M | ||
|
Agilent Technologies
A
|
28.3 | $ 118.3 | 0.66 % | $ 36 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 20.92 | 1.06 % | $ 1.11 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.62 | 1.89 % | $ 2.15 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 24.62 | 0.08 % | $ 684 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 425.43 | -1.14 % | $ 12.3 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 181.35 | -2.18 % | $ 8.99 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.17 | -17.1 % | $ 386 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.93 | 0.79 % | $ 1.14 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
11.9 | $ 18.01 | -3.9 % | $ 403 M | ||
|
Natera
NTRA
|
-12.3 | $ 215.74 | 4.34 % | $ 21.2 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 14.95 | 0.34 % | $ 452 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.28 | 3.14 % | $ 20 B | ||
|
Personalis
PSNL
|
-5.62 | $ 6.04 | 8.63 % | $ 358 M | ||
|
Guardant Health
GH
|
-72.7 | $ 91.76 | 2.5 % | $ 11.5 B | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.94 | 0.04 % | $ 2.69 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 124.55 | 2.66 % | $ 10.3 B | ||
|
Illumina
ILMN
|
19.6 | $ 142.45 | 2.43 % | $ 22.6 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 5.36 | 7.2 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 2.11 | 5.09 % | $ 9.33 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 473.47 | 1.44 % | $ 178 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.17 | -0.69 % | $ 4.98 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 86.15 | 0.38 % | $ 5.81 B | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.61 | 1.75 % | $ 61.9 M | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 257.95 | 0.32 % | $ 21.5 B | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 59.72 | 5.33 % | $ 3.57 B | ||
|
Celcuity
CELC
|
-35 | $ 138.9 | -1.97 % | $ 6.49 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.16 | -1.19 % | $ 1.99 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 188.65 | -1.15 % | $ 20.9 B | ||
|
Waters Corporation
WAT
|
30.1 | $ 348.15 | 1.58 % | $ 20.7 B |